Steven L Bernstein1, June-Marie Weiss2, Benjamin Toll3, Susan M Zbikowski4. 1. Department of Emergency Medicine, New Haven, CT, United States; Yale Comprehensive Cancer Center, New Haven, CT, United States; Yale School of Medicine, New Haven, CT, United States. Electronic address: Steven.bernstein@yale.edu. 2. Department of Emergency Medicine, New Haven, CT, United States; Yale School of Medicine, New Haven, CT, United States. 3. Department of Psychiatry, New Haven, CT, United States; Yale Comprehensive Cancer Center, New Haven, CT, United States; Yale School of Medicine, New Haven, CT, United States; Medical University of South Carolina, Seattle, WA, United States; Hollings Cancer Center, Seattle, WA, United States. 4. Alere Wellbeing, Inc., Seattle, WA, United States.
Abstract
INTRODUCTION:Quitlines (QL) are an effective means for smoking cessation, but a paucity of data exist examining the dose-response relationship between use of QL services and quit rates, especially among low-income smokers. The purpose of this study was to study the relationship between tobacco abstinence and use of QL services among low-income smokers. METHODS: Secondary analysis of a randomized trial of every- or some-day smokers aged 18 years or older visiting an urban emergency department. Inclusion criteria included self-pay or Medicaid insurance, as a proxy for low-income and low socioeconomic status. Intervention participants received a motivational interview, 6 weeks of nicotine patches and gum, a referral faxed to the state-sponsored QL, a booster call, and a quitline brochure. Control participants received the brochure. Smoking status was assessed by phone at 1 and 3 months, with confirmation via exhaled carbon monoxide testing at 3 months for those reporting abstinence. QL usage was obtained by utilization data from the QL database. RESULTS:Of 778 subjects, 197 (25.3%) reported any use of QL services at 3 months. Participants were trichotomized: no QL usage, 1 call only, and >1 call (583, 99, and 98 participants, respectively). Quit rates at 3 months in these no, low-, and high-use groups were, respectively, 7.2%, 9.1%, and 15.3% (P=0.03). Participants who used the QL had a median of 28 total minutes of telephone contact. CONCLUSION: Among low-income smokers, greater use of QL services is associated with higher abstinence. Whether this resulted from a direct effect of the QL, or greater motivation among smokers using QL services cannot be determined from these data.
RCT Entities:
INTRODUCTION: Quitlines (QL) are an effective means for smoking cessation, but a paucity of data exist examining the dose-response relationship between use of QL services and quit rates, especially among low-income smokers. The purpose of this study was to study the relationship between tobacco abstinence and use of QL services among low-income smokers. METHODS: Secondary analysis of a randomized trial of every- or some-day smokers aged 18 years or older visiting an urban emergency department. Inclusion criteria included self-pay or Medicaid insurance, as a proxy for low-income and low socioeconomic status. Intervention participants received a motivational interview, 6 weeks of nicotine patches and gum, a referral faxed to the state-sponsored QL, a booster call, and a quitline brochure. Control participants received the brochure. Smoking status was assessed by phone at 1 and 3 months, with confirmation via exhaled carbon monoxide testing at 3 months for those reporting abstinence. QL usage was obtained by utilization data from the QL database. RESULTS: Of 778 subjects, 197 (25.3%) reported any use of QL services at 3 months. Participants were trichotomized: no QL usage, 1 call only, and >1 call (583, 99, and 98 participants, respectively). Quit rates at 3 months in these no, low-, and high-use groups were, respectively, 7.2%, 9.1%, and 15.3% (P=0.03). Participants who used the QL had a median of 28 total minutes of telephone contact. CONCLUSION: Among low-income smokers, greater use of QL services is associated with higher abstinence. Whether this resulted from a direct effect of the QL, or greater motivation among smokers using QL services cannot be determined from these data.
Authors: Shu-Hong Zhu; Christopher M Anderson; Gary J Tedeschi; Bradley Rosbrook; Cynthia E Johnson; Michael Byrd; Elsa Gutiérrez-Terrell Journal: N Engl J Med Date: 2002-10-03 Impact factor: 91.245
Authors: Jack F Hollis; Timothy A McAfee; Jeffrey L Fellows; Susan M Zbikowski; Michael Stark; Karen Riedlinger Journal: Tob Control Date: 2007-12 Impact factor: 7.552
Authors: Laura L Biazzo; Desireé B Froshaug; Todd S Harwell; Heather N Beck; Cynthia Haugland; Stacy L Campbell; Steven D Helgerson Journal: Nicotine Tob Res Date: 2010-04-08 Impact factor: 4.244
Authors: Gary E Swan; Lisa M Jack; Sue Curry; Michael Chorost; Harold Javitz; Tim McAfee; Sara Dacey Journal: Nicotine Tob Res Date: 2003-12 Impact factor: 4.244
Authors: Susan A Flocke; Robin Vanderpool; Genevieve Birkby; Heidi Gullett; Elizabeth L Seaman; Stephanie Land; Steve Zeliadt Journal: J Health Care Poor Underserved Date: 2019
Authors: Steven L Bernstein; James Dziura; June Weiss; Ted Miller; Katrina A Vickerman; Lauretta E Grau; Michael V Pantalon; Lorien Abroms; Linda M Collins; Benjamin Toll Journal: Contemp Clin Trials Date: 2017-12-27 Impact factor: 2.226
Authors: Terry Bush; Jennifer Lovejoy; Harold Javitz; Alula Jimenez Torres; Ken Wassum; Marcia M Tan; Bonnie Spring Journal: BMC Public Health Date: 2018-05-31 Impact factor: 3.295
Authors: Bárbara Piñeiro; David W Wetter; Damon J Vidrine; Diana S Hoover; Summer G Frank-Pearce; Nga Nguyen; Susan M Zbikowski; Mary B Williams; Jennifer I Vidrine Journal: Prev Med Rep Date: 2019-01-17
Authors: Christi A Patten; Steven Fu; Katrina Vickerman; Martha J Bock; David Nelson; Shu-Hong Zhu; Joyce E Balls-Berry; Alula Jimenez Torres; Tabetha A Brockman; Christine A Hughes; Abigail E Klein; Miguel Valdez-Soto; Paula A Keller Journal: Addict Behav Rep Date: 2019-02-12
Authors: Marcia M Tan; Terry Bush; Jennifer C Lovejoy; Harold Javitz; Alula Jimenez Torres; Ken Wassum; Bonnie Spring Journal: Prev Med Rep Date: 2020-12-29
Authors: Ashley L Merianos; Roman A Jandarov; Judith S Gordon; Michael S Lyons; E Melinda Mahabee-Gittens Journal: PLoS One Date: 2021-02-23 Impact factor: 3.240